Glioma Diagnosis and Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
A glioma is a type of tumor that originates in the brain. There are numerous types of gliomas differentiated on the basis of origin of the cell type such as oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Technological advancements in the diagnosis of gliomas and analysis of its progression are driving the growth of the market.
MARKET DYNAMICS
The glioma diagnosis and treatment market is driving due to increasing prevalence of brain cancer, and innovations in drug delivery to brain cancer. However, lack of adoption in low-income countries is expected to hamper the growth of the global glioma diagnosis and treatment market. Moreover, the introduction of novel therapies coupled with increasing geriatric population are is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Glioma Diagnosis and Treatment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of glioma diagnosis and treatment market with detailed market segmentation by type, diagnosis, treatment, and end-user. The glioma diagnosis and treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in glioma diagnosis and treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The glioma diagnosis and treatment market is segmented based on type, diagnosis, treatment, and end-user. Based on type, the market is segmented into primary tumor, secondary tumor. Primary tumor is segmented into ependymomas, astrocytomas, oligodendrogliomas, brainstem glioma, others. Based on diagnosis, the market is segmented into neurological exam, computed tomography (CT) scan, magnetic resonance imaging (MRI), biopsy, position emission tomography (PET) scan, others. Based on treatment, the market is segmented into surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glioma diagnosis and treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glioma diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting glioma diagnosis and treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the glioma diagnosis and treatment market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glioma diagnosis and treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glioma diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting glioma diagnosis and treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the glioma diagnosis and treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the glioma diagnosis and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glioma Diagnosis and Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for glioma diagnosis and treatment market in the global market. Below mentioned is the list of few companies engaged in the glioma diagnosis and treatment market.
The report also includes the profiles of key players in Glioma Diagnosis and Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific
- Pfizer Inc.
- Novartis AG
- Sun Pharmaceuticals Ltd
- GE Healthcare
- Shimadzu Corporation
- Siemens Healthcare
- TOSHIBA Medical Systems
- AbbVie Inc.
- Eisai Inc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glioma Diagnosis And Treatment Market - By Type
1.3.2 Glioma Diagnosis And Treatment Market - By Diagnosis
1.3.3 Glioma Diagnosis And Treatment Market - By Treatment
1.3.4 Glioma Diagnosis And Treatment Market - By End User
1.3.5 Glioma Diagnosis And Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GLIOMA DIAGNOSIS AND TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GLIOMA DIAGNOSIS AND TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GLIOMA DIAGNOSIS AND TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. GLIOMA DIAGNOSIS AND TREATMENT - GLOBAL MARKET OVERVIEW
6.2. GLIOMA DIAGNOSIS AND TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRIMARY TUMOR
7.3.1. Overview
7.3.2. Primary Tumor Market Forecast and Analysis
7.3.3. Ependymomas Market
7.3.3.1. Overview
7.3.3.2. Ependymomas Market Forecast and Analysis
7.3.4. Astrocytomas Market
7.3.4.1. Overview
7.3.4.2. Astrocytomas Market Forecast and Analysis
7.3.5. Oligodendrogliomas Market
7.3.5.1. Overview
7.3.5.2. Oligodendrogliomas Market Forecast and Analysis
7.3.6. Brainstem Glioma Market
7.3.6.1. Overview
7.3.6.2. Brainstem Glioma Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. SECONDARY TUMOR
7.4.1. Overview
7.4.2. Secondary Tumor Market Forecast and Analysis
8. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. NEUROLOGICAL EXAM
8.3.1. Overview
8.3.2. Neurological Exam Market Forecast and Analysis
8.4. COMPUTED TOMOGRAPHY (CT) SCAN
8.4.1. Overview
8.4.2. Computed Tomography (CT) Scan Market Forecast and Analysis
8.5. MAGNETIC RESONANCE IMAGING (MRI)
8.5.1. Overview
8.5.2. Magnetic Resonance Imaging (MRI) Market Forecast and Analysis
8.6. BIOPSY
8.6.1. Overview
8.6.2. Biopsy Market Forecast and Analysis
8.7. POSITION EMISSION TOMOGRAPHY (PET) SCAN
8.7.1. Overview
8.7.2. Position Emission Tomography (PET) Scan Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. SURGERY
9.3.1. Overview
9.3.2. Surgery Market Forecast and Analysis
9.4. CHEMOTHERAPY
9.4.1. Overview
9.4.2. Chemotherapy Market Forecast and Analysis
9.5. RADIATION THERAPY
9.5.1. Overview
9.5.2. Radiation Therapy Market Forecast and Analysis
9.6. IMMUNOTHERAPY
9.6.1. Overview
9.6.2. Immunotherapy Market Forecast and Analysis
9.7. TARGETED THERAPY
9.7.1. Overview
9.7.2. Targeted Therapy Market Forecast and Analysis
10. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DIAGNOSTIC CENTERS
10.4.1. Overview
10.4.2. Diagnostic Centers Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. GLIOMA DIAGNOSIS AND TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Glioma Diagnosis And Treatment Market Overview
11.1.2 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.1.3 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.1.4 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.1.5 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.1.6 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.1.7 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Glioma Diagnosis And Treatment Market
11.1.7.1.1 United States Glioma Diagnosis And Treatment Market by Type
11.1.7.1.2 United States Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.1.3 United States Glioma Diagnosis And Treatment Market by Treatment
11.1.7.1.4 United States Glioma Diagnosis And Treatment Market by End User
11.1.7.2 Canada Glioma Diagnosis And Treatment Market
11.1.7.2.1 Canada Glioma Diagnosis And Treatment Market by Type
11.1.7.2.2 Canada Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.2.3 Canada Glioma Diagnosis And Treatment Market by Treatment
11.1.7.2.4 Canada Glioma Diagnosis And Treatment Market by End User
11.1.7.3 Mexico Glioma Diagnosis And Treatment Market
11.1.7.3.1 Mexico Glioma Diagnosis And Treatment Market by Type
11.1.7.3.2 Mexico Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.3.3 Mexico Glioma Diagnosis And Treatment Market by Treatment
11.1.7.3.4 Mexico Glioma Diagnosis And Treatment Market by End User
11.2. EUROPE
11.2.1 Europe Glioma Diagnosis And Treatment Market Overview
11.2.2 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.2.3 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.2.4 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.2.5 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.2.6 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.2.7 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Glioma Diagnosis And Treatment Market
11.2.7.1.1 Germany Glioma Diagnosis And Treatment Market by Type
11.2.7.1.2 Germany Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.1.3 Germany Glioma Diagnosis And Treatment Market by Treatment
11.2.7.1.4 Germany Glioma Diagnosis And Treatment Market by End User
11.2.7.2 France Glioma Diagnosis And Treatment Market
11.2.7.2.1 France Glioma Diagnosis And Treatment Market by Type
11.2.7.2.2 France Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.2.3 France Glioma Diagnosis And Treatment Market by Treatment
11.2.7.2.4 France Glioma Diagnosis And Treatment Market by End User
11.2.7.3 Italy Glioma Diagnosis And Treatment Market
11.2.7.3.1 Italy Glioma Diagnosis And Treatment Market by Type
11.2.7.3.2 Italy Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.3.3 Italy Glioma Diagnosis And Treatment Market by Treatment
11.2.7.3.4 Italy Glioma Diagnosis And Treatment Market by End User
11.2.7.4 Spain Glioma Diagnosis And Treatment Market
11.2.7.4.1 Spain Glioma Diagnosis And Treatment Market by Type
11.2.7.4.2 Spain Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.4.3 Spain Glioma Diagnosis And Treatment Market by Treatment
11.2.7.4.4 Spain Glioma Diagnosis And Treatment Market by End User
11.2.7.5 United Kingdom Glioma Diagnosis And Treatment Market
11.2.7.5.1 United Kingdom Glioma Diagnosis And Treatment Market by Type
11.2.7.5.2 United Kingdom Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.5.3 United Kingdom Glioma Diagnosis And Treatment Market by Treatment
11.2.7.5.4 United Kingdom Glioma Diagnosis And Treatment Market by End User
11.2.7.6 Rest of Europe Glioma Diagnosis And Treatment Market
11.2.7.6.1 Rest of Europe Glioma Diagnosis And Treatment Market by Type
11.2.7.6.2 Rest of Europe Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.6.3 Rest of Europe Glioma Diagnosis And Treatment Market by Treatment
11.2.7.6.4 Rest of Europe Glioma Diagnosis And Treatment Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Glioma Diagnosis And Treatment Market Overview
11.3.2 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.3.5 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Glioma Diagnosis And Treatment Market
11.3.7.1.1 Australia Glioma Diagnosis And Treatment Market by Type
11.3.7.1.2 Australia Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.1.3 Australia Glioma Diagnosis And Treatment Market by Treatment
11.3.7.1.4 Australia Glioma Diagnosis And Treatment Market by End User
11.3.7.2 China Glioma Diagnosis And Treatment Market
11.3.7.2.1 China Glioma Diagnosis And Treatment Market by Type
11.3.7.2.2 China Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.2.3 China Glioma Diagnosis And Treatment Market by Treatment
11.3.7.2.4 China Glioma Diagnosis And Treatment Market by End User
11.3.7.3 India Glioma Diagnosis And Treatment Market
11.3.7.3.1 India Glioma Diagnosis And Treatment Market by Type
11.3.7.3.2 India Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.3.3 India Glioma Diagnosis And Treatment Market by Treatment
11.3.7.3.4 India Glioma Diagnosis And Treatment Market by End User
11.3.7.4 Japan Glioma Diagnosis And Treatment Market
11.3.7.4.1 Japan Glioma Diagnosis And Treatment Market by Type
11.3.7.4.2 Japan Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.4.3 Japan Glioma Diagnosis And Treatment Market by Treatment
11.3.7.4.4 Japan Glioma Diagnosis And Treatment Market by End User
11.3.7.5 South Korea Glioma Diagnosis And Treatment Market
11.3.7.5.1 South Korea Glioma Diagnosis And Treatment Market by Type
11.3.7.5.2 South Korea Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.5.3 South Korea Glioma Diagnosis And Treatment Market by Treatment
11.3.7.5.4 South Korea Glioma Diagnosis And Treatment Market by End User
11.3.7.6 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Type
11.3.7.6.2 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.6.3 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Treatment
11.3.7.6.4 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Glioma Diagnosis And Treatment Market Overview
11.4.2 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.4.5 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Glioma Diagnosis And Treatment Market
11.4.7.1.1 South Africa Glioma Diagnosis And Treatment Market by Type
11.4.7.1.2 South Africa Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.1.3 South Africa Glioma Diagnosis And Treatment Market by Treatment
11.4.7.1.4 South Africa Glioma Diagnosis And Treatment Market by End User
11.4.7.2 Saudi Arabia Glioma Diagnosis And Treatment Market
11.4.7.2.1 Saudi Arabia Glioma Diagnosis And Treatment Market by Type
11.4.7.2.2 Saudi Arabia Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.2.3 Saudi Arabia Glioma Diagnosis And Treatment Market by Treatment
11.4.7.2.4 Saudi Arabia Glioma Diagnosis And Treatment Market by End User
11.4.7.3 U.A.E Glioma Diagnosis And Treatment Market
11.4.7.3.1 U.A.E Glioma Diagnosis And Treatment Market by Type
11.4.7.3.2 U.A.E Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.3.3 U.A.E Glioma Diagnosis And Treatment Market by Treatment
11.4.7.3.4 U.A.E Glioma Diagnosis And Treatment Market by End User
11.4.7.4 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Type
11.4.7.4.2 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.4.3 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Treatment
11.4.7.4.4 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Glioma Diagnosis And Treatment Market Overview
11.5.2 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.5.3 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.5.4 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.5.5 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.5.7 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Glioma Diagnosis And Treatment Market
11.5.7.1.1 Brazil Glioma Diagnosis And Treatment Market by Type
11.5.7.1.2 Brazil Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.1.3 Brazil Glioma Diagnosis And Treatment Market by Treatment
11.5.7.1.4 Brazil Glioma Diagnosis And Treatment Market by End User
11.5.7.2 Argentina Glioma Diagnosis And Treatment Market
11.5.7.2.1 Argentina Glioma Diagnosis And Treatment Market by Type
11.5.7.2.2 Argentina Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.2.3 Argentina Glioma Diagnosis And Treatment Market by Treatment
11.5.7.2.4 Argentina Glioma Diagnosis And Treatment Market by End User
11.5.7.3 Rest of South and Central America Glioma Diagnosis And Treatment Market
11.5.7.3.1 Rest of South and Central America Glioma Diagnosis And Treatment Market by Type
11.5.7.3.2 Rest of South and Central America Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.3.3 Rest of South and Central America Glioma Diagnosis And Treatment Market by Treatment
11.5.7.3.4 Rest of South and Central America Glioma Diagnosis And Treatment Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GLIOMA DIAGNOSIS AND TREATMENT MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. GLIOMA DIAGNOSIS AND TREATMENT MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PFIZER INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. NOVARTIS AG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. SUN PHARMACEUTICALS LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GE HEALTHCARE
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. SHIMADZU CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. SIEMENS HEALTHCARE
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. TOSHIBA MEDICAL SYSTEMS
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ABBVIE INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. EISAI INC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Thermo Fisher Scientific
2. Pfizer Inc.
3. Novartis AG
4. Sun Pharmaceuticals Ltd
5. GE Healthcare
6. Shimadzu Corporation
7. Siemens Healthcare
8. TOSHIBA Medical Systems
9. AbbVie Inc.
10. Eisai Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For